Published in Mol Cell on June 11, 2010
Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication. Cell Host Microbe (2011) 1.43
Cancer associated human papillomaviruses. Curr Opin Virol (2012) 1.25
Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses. Virology (2012) 1.23
Papillomavirus E6 oncoproteins. Virology (2013) 1.21
Differential effects on p53-mediated cell cycle arrest vs. apoptosis by p90. Proc Natl Acad Sci U S A (2011) 1.04
A protein array screen for Kaposi's sarcoma-associated herpesvirus LANA interactors links LANA to TIP60, PP2A activity, and telomere shortening. J Virol (2012) 0.98
Tip60 degradation by adenovirus relieves transcriptional repression of viral transcriptional activator EIA. Oncogene (2012) 0.96
Recurrent respiratory papillomatosis. Otolaryngol Clin North Am (2012) 0.92
Deubiquitination of Tip60 by USP7 determines the activity of the p53-dependent apoptotic pathway. Mol Cell Biol (2013) 0.91
Viral takeover of the host ubiquitin system. Front Microbiol (2011) 0.90
Current understanding of the role of the Brd4 protein in the papillomavirus lifecycle. Viruses (2013) 0.89
Microarray analysis uncovers a role for Tip60 in nervous system function and general metabolism. PLoS One (2011) 0.88
Defective nuclear import of Tpr in Progeria reflects the Ran sensitivity of large cargo transport. J Cell Biol (2013) 0.87
TIP60-miR-22 axis as a prognostic marker of breast cancer progression. Oncotarget (2015) 0.87
RVBs are required for assembling a functional TIP60 complex. Mol Cell Biol (2013) 0.87
The HPV E6 oncoprotein targets histone methyltransferases for modulating specific gene transcription. Oncogene (2011) 0.87
Changing the ubiquitin landscape during viral manipulation of the DNA damage response. FEBS Lett (2011) 0.86
Nuclear matrix protein SMAR1 represses c-Fos-mediated HPV18 E6 transcription through alteration of chromatin histone deacetylation. J Biol Chem (2014) 0.85
HPV-18 E6 mutants reveal p53 modulation of viral DNA amplification in organotypic cultures. Proc Natl Acad Sci U S A (2013) 0.85
An unbiased in vivo screen reveals multiple transcription factors that control HPV E6-regulated hTERT in keratinocytes. Virology (2013) 0.85
The acetyltransferase Tip60 is a critical regulator of the differentiation-dependent amplification of human papillomaviruses. J Virol (2015) 0.84
E3 ligase EDD1/UBR5 is utilized by the HPV E6 oncogene to destabilize tumor suppressor TIP60. Oncogene (2015) 0.81
Negative regulation of the acetyltransferase TIP60-p53 interplay by UHRF1 (ubiquitin-like with PHD and RING finger domains 1). J Biol Chem (2013) 0.81
The Ying-Yang of the virus-host interaction: control of the DNA damage response. Future Microbiol (2011) 0.81
Phosphoproteomic Profiling Reveals Epstein-Barr Virus Protein Kinase Integration of DNA Damage Response and Mitotic Signaling. PLoS Pathog (2015) 0.81
The stress-responsive gene ATF3 regulates the histone acetyltransferase Tip60. Nat Commun (2015) 0.79
SMCX and components of the TIP60 complex contribute to E2 regulation of the HPV E6/E7 promoter. Virology (2014) 0.79
Human papillomavirus infections: warts or cancer? Cold Spring Harb Perspect Biol (2013) 0.78
HPV16 oncogene expression levels during early cervical carcinogenesis are determined by the balance of epigenetic chromatin modifications at the integrated virus genome. Oncogene (2016) 0.78
Proteomic approaches to uncovering virus-host protein interactions during the progression of viral infection. Expert Rev Proteomics (2016) 0.77
Antagonistic Relationship between Human Cytomegalovirus pUL27 and pUL97 Activities during Infection. J Virol (2015) 0.76
Ad E1A 243R oncoprotein promotes association of proto-oncogene product MYC with the NuA4/Tip60 complex via the E1A N-terminal repression domain. Virology (2016) 0.76
Human papillomavirus 16 oncoprotein E7 stimulates UBF1-mediated rDNA gene transcription, inhibiting a p53-independent activity of p14ARF. PLoS One (2014) 0.75
E6 proteins from low-risk human papillomavirus types 6 and 11 are able to protect keratinocytes from apoptosis via Bak degradation. J Gen Virol (2016) 0.75
Genomic instability: Ada3 and HPV E6-acetyltransferase connections? Cell Cycle (2012) 0.75
Regulation of the human papillomavirus type 16 late promoter by transcriptional elongation. Virology (2017) 0.75
Sterile α Motif Domain Containing 9 Is a Novel Cellular Interacting Partner to Low-Risk Type Human Papillomavirus E6 Proteins. PLoS One (2016) 0.75
Epigenetic Alterations in Human Papillomavirus-Associated Cancers. Viruses (2017) 0.75
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell (1990) 20.60
Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer (2002) 15.46
Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem (2004) 14.93
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell (1993) 12.41
How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers. Nat Struct Mol Biol (2007) 10.98
Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev (2000) 9.36
Multivalent engagement of chromatin modifications by linked binding modules. Nat Rev Mol Cell Biol (2007) 8.14
Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO J (1986) 7.60
Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell (2000) 6.70
Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol Cell (2006) 5.64
Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol Cell (2006) 5.40
A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J (1991) 5.39
Histone acetylation by Trrap-Tip60 modulates loading of repair proteins and repair of DNA double-strand breaks. Nat Cell Biol (2005) 5.11
Acetylation by Tip60 is required for selective histone variant exchange at DNA lesions. Science (2004) 4.97
A phosphatase complex that dephosphorylates gammaH2AX regulates DNA damage checkpoint recovery. Nature (2005) 4.33
A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM. Proc Natl Acad Sci U S A (2005) 4.24
Acetylation of histone H4 by Esa1 is required for DNA double-strand break repair. Nature (2002) 4.18
Global position and recruitment of HATs and HDACs in the yeast genome. Mol Cell (2004) 3.74
Human papillomavirus immortalization and transformation functions. Virus Res (2002) 3.58
gamma-H2AX dephosphorylation by protein phosphatase 2A facilitates DNA double-strand break repair. Mol Cell (2005) 3.24
MYC recruits the TIP60 histone acetyltransferase complex to chromatin. EMBO Rep (2003) 3.24
ESA1 is a histone acetyltransferase that is essential for growth in yeast. Proc Natl Acad Sci U S A (1998) 3.19
The highly conserved and multifunctional NuA4 HAT complex. Curr Opin Genet Dev (2004) 3.03
DNA damage-dependent acetylation and ubiquitination of H2AX enhances chromatin dynamics. Mol Cell Biol (2007) 3.03
Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol Cell Biol (1993) 2.91
Pan-S replication patterns and chromosomal domains defined by genome-tiling arrays of ENCODE genomic areas. Genome Res (2007) 2.82
Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase. Mol Cell Biol (2000) 2.79
Tip60 in DNA damage response and growth control: many tricks in one HAT. Trends Cell Biol (2006) 2.68
Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response. Nature (2007) 2.54
DNA damage-induced acetylation of lysine 3016 of ATM activates ATM kinase activity. Mol Cell Biol (2007) 2.38
Brd4 links chromatin targeting to HPV transcriptional silencing. Genes Dev (2006) 2.36
Cellular functions of TIP60. Int J Biochem Cell Biol (2006) 2.28
E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation. Mol Cell (2005) 2.13
Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. Genes Dev (2009) 1.97
Tip60 and histone deacetylase 1 regulate androgen receptor activity through changes to the acetylation status of the receptor. J Biol Chem (2002) 1.95
Tip60 is targeted to proteasome-mediated degradation by Mdm2 and accumulates after UV irradiation. EMBO J (2002) 1.81
Identification of a negative regulatory domain in the human papillomavirus type 18 promoter: interaction with the transcriptional repressor YY1. EMBO J (1992) 1.74
Human Rvb1/Tip49 is required for the histone acetyltransferase activity of Tip60/NuA4 and for the downregulation of phosphorylation on H2AX after DNA damage. Mol Cell Biol (2008) 1.66
RVB1/RVB2: running rings around molecular biology. Mol Cell (2009) 1.62
Analysis of Myc-induced histone modifications on target chromatin. PLoS One (2008) 1.59
Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. Proc Natl Acad Sci U S A (2010) 1.57
Small DNA tumor viruses: large contributors to biomedical sciences. Virology (2009) 1.48
REGgamma, a proteasome activator and beyond? Cell Mol Life Sci (2008) 1.43
An eukaryotic RuvB-like protein (RUVBL1) essential for growth. J Biol Chem (1998) 1.37
The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation. Proc Natl Acad Sci U S A (2005) 1.31
The role of the ubiquitin ligase E6-AP in human papillomavirus E6-mediated degradation of PDZ domain-containing proteins. J Biol Chem (2006) 1.23
HPV E6 targeted degradation of the discs large protein: evidence for the involvement of a novel ubiquitin ligase. Oncogene (2000) 1.21
Brd4-independent transcriptional repression function of the papillomavirus e2 proteins. J Virol (2007) 1.19
HIV-1 Tat targets Tip60 to impair the apoptotic cell response to genotoxic stresses. EMBO J (2005) 1.14
Degradation of tyrosine phosphatase PTPN3 (PTPH1) by association with oncogenic human papillomavirus E6 proteins. J Virol (2006) 1.14
Axin determines cell fate by controlling the p53 activation threshold after DNA damage. Nat Cell Biol (2009) 1.13
Requirement of E6AP and the features of human papillomavirus E6 necessary to support degradation of p53. Virology (2003) 1.11
Casein kinase II motif-dependent phosphorylation of human papillomavirus E7 protein promotes p130 degradation and S-phase induction in differentiated human keratinocytes. J Virol (2008) 1.09
E6AP-dependent degradation of DLG4/PSD95 by high-risk human papillomavirus type 18 E6 protein. J Virol (2006) 1.08
Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6. J Med Virol (2006) 1.01
HPV16 E6 confers p53-dependent and p53-independent phenotypes in the epidermis of mice deficient for E6AP. Oncogene (2006) 1.00
Degradation of hDlg and MAGIs by human papillomavirus E6 is E6-AP-independent. J Gen Virol (2004) 0.99
Regulation of TIP60 by ATF2 modulates ATM activation. J Biol Chem (2008) 0.96
Transcription-modulatory activity of full-length E6 and E6*I proteins of human papillomavirus type 16. Virology (1994) 0.89
Cellular factor YY1 downregulates the human papillomavirus 16 E6/E7 promoter, P97, in vivo and in vitro from a negative element overlapping the transcription-initiation site. J Gen Virol (2009) 0.81
CCAAT/enhancer-binding protein beta represses human papillomavirus 11 upstream regulatory region expression through a promoter-proximal YY1-binding site. J Gen Virol (2006) 0.80
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature (2007) 75.09
DNA replication in eukaryotic cells. Annu Rev Biochem (2001) 13.39
The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev (2007) 10.15
p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer (2009) 9.21
Preventing re-replication of chromosomal DNA. Nat Rev Mol Cell Biol (2005) 5.82
Muscle-specific microRNA miR-206 promotes muscle differentiation. J Cell Biol (2006) 5.78
A novel class of small RNAs: tRNA-derived RNA fragments (tRFs). Genes Dev (2009) 5.04
Small RNAs with imperfect match to endogenous mRNA repress translation. Implications for off-target activity of small inhibitory RNA in mammalian cells. J Biol Chem (2003) 4.57
MicroRNAs in cancer. Annu Rev Pathol (2009) 4.47
Right place, right time, and only once: replication initiation in metazoans. Cell (2005) 3.61
PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex. Genes Dev (2008) 3.49
A p53-dependent checkpoint pathway prevents rereplication. Mol Cell (2003) 3.42
Depletion of human micro-RNA miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the down-regulation of putative targets during differentiation. J Biol Chem (2005) 3.33
Rereplication by depletion of geminin is seen regardless of p53 status and activates a G2/M checkpoint. Mol Cell Biol (2004) 3.06
PCNA is a cofactor for Cdt1 degradation by CUL4/DDB1-mediated N-terminal ubiquitination. J Biol Chem (2006) 2.96
Temporal profile of replication of human chromosomes. Proc Natl Acad Sci U S A (2005) 2.85
Pan-S replication patterns and chromosomal domains defined by genome-tiling arrays of ENCODE genomic areas. Genome Res (2007) 2.82
Xenopus Mcm10 binds to origins of DNA replication after Mcm2-7 and stimulates origin binding of Cdc45. Mol Cell (2002) 2.55
UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation. Mol Cell (2006) 2.51
The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1. J Biol Chem (2009) 2.40
CRL4(Cdt2) regulates cell proliferation and histone gene expression by targeting PR-Set7/Set8 for degradation. Mol Cell (2010) 2.32
Mcm10 and And-1/CTF4 recruit DNA polymerase alpha to chromatin for initiation of DNA replication. Genes Dev (2007) 2.17
miR-206 and -486 induce myoblast differentiation by downregulating Pax7. Mol Cell Biol (2010) 2.10
Deficiency of LKB1 in heart prevents ischemia-mediated activation of AMPKalpha2 but not AMPKalpha1. Am J Physiol Endocrinol Metab (2005) 2.04
The APC/C inhibitor, Emi1, is essential for prevention of rereplication. Genes Dev (2007) 2.03
miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation. Cancer Res (2011) 2.02
DNA replication and progression through S phase. Oncogene (2005) 1.99
Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. Genes Dev (2009) 1.97
Genomic study of replication initiation in human chromosomes reveals the influence of transcription regulation and chromatin structure on origin selection. Mol Biol Cell (2009) 1.94
MiR-322/424 and -503 are induced during muscle differentiation and promote cell cycle quiescence and differentiation by down-regulation of Cdc25A. Mol Biol Cell (2010) 1.89
Rvb1p/Rvb2p recruit Arp5p and assemble a functional Ino80 chromatin remodeling complex. Mol Cell (2004) 1.88
NEDD8-targeting drug MLN4924 elicits DNA rereplication by stabilizing Cdt1 in S phase, triggering checkpoint activation, apoptosis, and senescence in cancer cells. Cancer Res (2010) 1.87
CRL4(Cdt2) E3 ubiquitin ligase monoubiquitinates PCNA to promote translesion DNA synthesis. Mol Cell (2010) 1.71
Human Rvb1/Tip49 is required for the histone acetyltransferase activity of Tip60/NuA4 and for the downregulation of phosphorylation on H2AX after DNA damage. Mol Cell Biol (2008) 1.66
The H19 long noncoding RNA gives rise to microRNAs miR-675-3p and miR-675-5p to promote skeletal muscle differentiation and regeneration. Genes Dev (2014) 1.64
MicroRNAs: small but potent oncogenes or tumor suppressors. Curr Opin Investig Drugs (2006) 1.63
RVB1/RVB2: running rings around molecular biology. Mol Cell (2009) 1.62
Mechanisms to control rereplication and implications for cancer. Curr Opin Cell Biol (2007) 1.61
Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA (2009) 1.60
Clonal selection for transcriptionally active viral oncogenes during progression to cancer. J Virol (2004) 1.56
A dimerized coiled-coil domain and an adjoining part of geminin interact with two sites on Cdt1 for replication inhibition. Mol Cell (2004) 1.48
Degradation of Cdt1 during S phase is Skp2-independent and is required for efficient progression of mammalian cells through S phase. J Biol Chem (2005) 1.47
miR-26a is required for skeletal muscle differentiation and regeneration in mice. Genes Dev (2012) 1.46
CRL4Cdt2: master coordinator of cell cycle progression and genome stability. Cell Cycle (2011) 1.45
Recruitment of ORC or CDC6 to DNA is sufficient to create an artificial origin of replication in mammalian cells. Genes Dev (2005) 1.42
Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma. Breast Cancer Res Treat (2007) 1.41
UBE2T, the Fanconi anemia core complex, and FANCD2 are recruited independently to chromatin: a basis for the regulation of FANCD2 monoubiquitination. Mol Cell Biol (2007) 1.40
Acute reduction of an origin recognition complex (ORC) subunit in human cells reveals a requirement of ORC for Cdk2 activation. J Biol Chem (2005) 1.40
The origin recognition complex localizes to telomere repeats and prevents telomere-circle formation. Curr Biol (2007) 1.36
MicroRNA-378 targets the myogenic repressor MyoR during myoblast differentiation. J Biol Chem (2011) 1.36
Bubble-chip analysis of human origin distributions demonstrates on a genomic scale significant clustering into zones and significant association with transcription. Genome Res (2010) 1.31
Geminin-Cdt1 balance is critical for genetic stability. Mutat Res (2005) 1.31
p130-angiomotin associates to actin and controls endothelial cell shape. FEBS J (2006) 1.31
An ATR- and BRCA1-mediated Fanconi anemia pathway is required for activating the G2/M checkpoint and DNA damage repair upon rereplication. Mol Cell Biol (2006) 1.27
ATR pathway is the primary pathway for activating G2/M checkpoint induction after re-replication. J Biol Chem (2007) 1.26
microRNAs are biomarkers of oncogenic human papillomavirus infections. Proc Natl Acad Sci U S A (2014) 1.25
Expression of geminin as a marker of cell proliferation in normal tissues and malignancies. Am J Pathol (2002) 1.24
Genomic instability in cancer. Cold Spring Harb Perspect Biol (2013) 1.23
The SKP1-Cul1-F-box and leucine-rich repeat protein 4 (SCF-FbxL4) ubiquitin ligase regulates lysine demethylase 4A (KDM4A)/Jumonji domain-containing 2A (JMJD2A) protein. J Biol Chem (2011) 1.22
Human papillomavirus (HPV) origin-binding protein associates with mitotic spindles to enable viral DNA partitioning. Proc Natl Acad Sci U S A (2004) 1.22
Structural basis for hijacking of cellular LxxLL motifs by papillomavirus E6 oncoproteins. Science (2013) 1.22
The effect of the intra-S-phase checkpoint on origins of replication in human cells. Genes Dev (2011) 1.21
Paxillin null embryonic stem cells are impaired in cell spreading and tyrosine phosphorylation of focal adhesion kinase. Oncogene (2002) 1.17
Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma. Neoplasia (2011) 1.17
Global effects of human papillomavirus type 18 E6/E7 in an organotypic keratinocyte culture system. J Virol (2004) 1.16
Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells. Mol Cancer Ther (2006) 1.16
Cyclin/CDK regulates the nucleocytoplasmic localization of the human papillomavirus E1 DNA helicase. J Virol (2004) 1.15
Promotion of incisional wound repair by human mesenchymal stem cell transplantation. Exp Dermatol (2008) 1.14
Construction of a full transcription map of human papillomavirus type 18 during productive viral infection. J Virol (2011) 1.11
Extrachromosomal microDNAs and chromosomal microdeletions in normal tissues. Science (2012) 1.11
Human papillomavirus (HPV) E7 induces prolonged G2 following S phase reentry in differentiated human keratinocytes. J Biol Chem (2011) 1.11
Requirement of E6AP and the features of human papillomavirus E6 necessary to support degradation of p53. Virology (2003) 1.11
Adipose-derived stromal cells accelerate wound healing in an organotypic raft culture model. Ann Plast Surg (2012) 1.10
Casein kinase II motif-dependent phosphorylation of human papillomavirus E7 protein promotes p130 degradation and S-phase induction in differentiated human keratinocytes. J Virol (2008) 1.09
Architecture of the pontin/reptin complex, essential in the assembly of several macromolecular complexes. Structure (2008) 1.09
Long non-coding RNAs as emerging regulators of differentiation, development, and disease. Transcription (2014) 1.07
p21-dependent inhibition of colon cancer cell growth by mevastatin is independent of inhibition of G1 cyclin-dependent kinases. J Biol Chem (2003) 1.07
Chaperone proteins abrogate inhibition of the human papillomavirus (HPV) E1 replicative helicase by the HPV E2 protein. Mol Cell Biol (2002) 1.07
The role of microRNAs in glioma initiation and progression. Front Biosci (Landmark Ed) (2012) 1.07
Autocatalytic phosphorylation of CDK2 at the activating Thr160. Cell Cycle (2007) 1.06
E6 proteins from diverse papillomaviruses self-associate both in vitro and in vivo. J Mol Biol (2009) 1.05
CRL1-FBXO11 promotes Cdt2 ubiquitylation and degradation and regulates Pr-Set7/Set8-mediated cellular migration. Mol Cell (2013) 1.05
Dynamic localization of the human papillomavirus type 11 origin binding protein E2 through mitosis while in association with the spindle apparatus. J Virol (2006) 1.04
Targeted comparative RNA interference analysis reveals differential requirement of genes essential for cell proliferation. Mol Biol Cell (2006) 1.04
Overcoming platinum resistance in preclinical models of ovarian cancer using the neddylation inhibitor MLN4924. Mol Cancer Ther (2013) 1.03
The immortal strand hypothesis: how could it work? Cell (2008) 1.03
APC/C--the master controller of origin licensing? Cell Div (2007) 1.02
Mitogen-activated protein kinases activate the nuclear localization sequence of human papillomavirus type 11 E1 DNA helicase to promote efficient nuclear import. J Virol (2007) 1.01
Notch3 and Mef2c proteins are mutually antagonistic via Mkp1 protein and miR-1/206 microRNAs in differentiating myoblasts. J Biol Chem (2012) 1.01
Geminin and p53: deterrents to rereplication in human cancer cells. Cell Cycle (2003) 0.99
Human Cdt1 lacking the evolutionarily conserved region that interacts with MCM2-7 is capable of inducing re-replication. J Biol Chem (2008) 0.99
Alternative fates of keratinocytes transduced by human papillomavirus type 18 E7 during squamous differentiation. J Virol (2002) 0.99
Degradation of p12 subunit by CRL4Cdt2 E3 ligase inhibits fork progression after DNA damage. J Biol Chem (2013) 0.99
The MCM8-MCM9 complex promotes RAD51 recruitment at DNA damage sites to facilitate homologous recombination. Mol Cell Biol (2013) 0.98
Proliferating human cells hypomorphic for origin recognition complex 2 and pre-replicative complex formation have a defect in p53 activation and Cdk2 kinase activation. J Biol Chem (2006) 0.98
PIK3CA-mediated PI3-kinase signalling is essential for HPV-induced transformation in vitro. Mol Cancer (2011) 0.98
Detection of DNA fusion junctions for BCR-ABL translocations by Anchored ChromPET. Genome Med (2010) 0.97
Retrovirus-mediated gene transfer to analyze HPV gene regulation and protein functions in organotypic "raft" cultures. Methods Mol Med (2005) 0.95
mRNA splicing regulates human papillomavirus type 11 E1 protein production and DNA replication. J Virol (2003) 0.95